Lunsumio
NDC 50242-142 · Genentech, Inc.
Generic nameMosunetuzumab
Dosage formCONCENTRATE
RouteINTRAVENOUS
Active ingredient(s)MOSUNETUZUMAB
Strength30 mg/30mL
Marketing categoryBLA
Packages
50242-142-01 — 1 VIAL in 1 CARTON (50242-142-01) / 30 mL in 1 VIAL
Billed under HCPCS
J9350 — Injection, mosunetuzumab-axgb, 1 mg Medicare Part B payment limit (ASP + 6%): $674.50
Related Codes
Same active ingredient
FDA lists these products with the same active ingredient.
50242-159 — Mosunetuzumab, 50242-177 — Mosunetuzumab, 50242-201 — Mosunetuzumab